Prostate Cancer Trial, Recruiting (NCT00969111)

Prostate Cancer Trial, Recruiting NCT00969111 Sponsor: Proton Collaborative Group Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT00969111 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have prostate cancer that was treated mainly with surgery to remove the prostate (whether done through open surgery, keyhole surgery, or robot-assisted surgery).
Your PSA level (a blood marker for prostate cancer) was no higher than 20 ng/ml.

Who may not be able to join:

Your prostate cancer has spread to other parts of the body beyond the prostate area.
You have previously had chemotherapy (cancer-fighting drug treatment) for any reason.
You have had radiation treatment to the pelvis area in the past that would make it difficult to safely give the radiation planned in this trial.
You have active inflammatory bowel disease (such as active Crohn's disease, diverticulitis, or ulcerative colitis) that affects the rectum — though non-active versions of these conditions, or cases that do not affect the rectum, may be allowed (confirm with trial site).
You have had or currently have another type of cancer, other than certain common skin cancers, unless you have been cancer-free for at least 5 years.
You are currently taking Saw Palmetto (a herbal supplement) or methotrexate (a medication) and are not willing or able to stop taking them during the radiation treatment period.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT00969111

Sponsor: Proton Collaborative Group

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

More information: https://clinicaltrials.gov/study/NCT00969111

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have prostate cancer that was treated mainly with surgery to remove the prostate (whether done through open surgery, keyhole surgery, or robot-assisted surgery).
Your PSA level (a blood marker for prostate cancer) was no higher than 20 ng/ml.

Who may not be able to join:

Your prostate cancer has spread to other parts of the body beyond the prostate area.
You have previously had chemotherapy (cancer-fighting drug treatment) for any reason.
You have had radiation treatment to the pelvis area in the past that would make it difficult to safely give the radiation planned in this trial.
You have active inflammatory bowel disease (such as active Crohn's disease, diverticulitis, or ulcerative colitis) that affects the rectum — though non-active versions of these conditions, or cases that do not affect the rectum, may be allowed (confirm with trial site).
You have had or currently have another type of cancer, other than certain common skin cancers, unless you have been cancer-free for at least 5 years.
You are currently taking Saw Palmetto (a herbal supplement) or methotrexate (a medication) and are not willing or able to stop taking them during the radiation treatment period.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Proton Collaborative Group

Registry

ClinicalTrials.gov

Start date

1 August 2009

Est. completion

1 August 2031

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

The treatment-related rate of acute grade 3 gastrointestinal and genitourinary toxicity following treatment with proton based radiation therapy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov